At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 58 enrolled
Drug / intervention
Compound Herbal Formula (RHD-1) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function: a Randomized Controlled Trial
In Brief
A Phase 3 clinical trial evaluating Compound Herbal Formula (RHD-1) and dilute RHD-1 for Liver Dysfunction. Completed, enrolled 58 participants across 1 site.
Detailed Summary
The aim of the study is to examine whether the compound herbal formula (RHD-1) is effective on HBV Carrier With Abnormal Liver Function.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Dysfunction
CountriesTaiwan
CollaboratorsNational Yang Ming Chiao Tung University
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2011
Enrollment StartMay 2011
Primary CompletionJun 2012
Study CompletionSep 2012
TodayJul 2026
First PostedApr 19, 2011
Enrollment StartMay 1, 2011
Primary CompletionJun 1, 2012
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 15.2 years ago
Interventions
Compound Herbal Formula (RHD-1)other
100 ml/per day
dilute RHD-1other
100 ml/per day